INM
InMed Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.77
-0.03 ▼ -3.62%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$0.77
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -3.78 | Insider Own | 0.17% | Shs Outstand | 0.00B | Perf Week | -16.2% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -22.12% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 10.53% | Short Float | 3.14% | Perf Quarter | -41.59% |
| Income | -0.01B | P/S | 0.5 | EPS this Y | - | Inst Trans | -2.59% | Short Ratio | 0.95 | Perf Half Y | -64.31% |
| Sales | 0.00B | P/B | 0.23 | EPS next 5Y | - | ROA | -77.84% | Short Interest | 0.09M | Perf YTD | -27.26% |
| Book/sh | 3.42 | P/C | 0.32 | EPS past 3/5Y | 92.04% 60.38% | ROE | -97.2% | 52W High | -90.34% ($7.98) | Perf Year | -71.34% |
| Cash/sh | 2.4 | P/FCF | - | Sales past 3/5Y | 65.55% - | ROIC | -78.92% | 52W Low | 5.31% ($0.73) | Perf 3Y | -96.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 73.54% | Gross Margin | 16.96% | Volatility(W/M) | 8.49% 8.36% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | -0.94 | Sales Y/Y TTM | -6.73% | Oper. Margin | -174.01% | ATR (14) | 0.07 | Perf 10Y | -99.95% |
| Dividend Ex-Date | - | Quick Ratio | 5.3 | EPS Q/Q | 85.93% | Profit Margin | -170.07% | RSI (14) | 36.93 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.94 | Sales Q/Q | -26.22% | SMA20 | -9.52% ($0.85) | Beta | 0.44 | Target Price | $468.78 |
| Payout | - | Debt/Eq | 0.06 | Earnings | - | SMA50 | -22.18% ($0.99) | Rel Volume | 0.19 | Prev Close | $0.8 |
| Employees | 13 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -58.96% ($1.88) | Avg Volume(3M) | 0.10M | Price | $0.77 |
| IPO | 2008/11/17 | Option/Short | No/Yes | Trades | 66 | Volume | 18,194 | Change | -3.62% |
뉴스 로딩 중...